Mika Doustdar

Mika Doustdar is the newly appointed CEO of Novo Nordisk, taking over the role on August 7, 2023. He previously served as the Executive Vice President for International Operations at the company. Doustdar's appointment comes during a tumultuous period for Novo Nordisk, which has experienced a significant drop in its stock value and market position due to increased competition in the weight loss medication sector, particularly from rival Eli Lilly. As CEO, Doustdar faces the challenge of navigating the company through these difficulties and restoring investor confidence.